Biographical summary
Karen L. Rech, M.D. practices in the Division of Hematopathology, with a special interest in the diagnosis of malignant lymphoma.
- Expertise in diagnosis of hematolymphoid neoplasms, including lymphoma, bone marrow disorders and histiocytic/dendritic cell neoplasms.
- Expertise in integration of ancillary studies for diagnosis including immunohistochemistry, flow cytometry, molecular genetic testing and amyloid typing by mass spectrometry.
- Member of the Mayo Clinic Histiocytosis Working Group.
- Medical Director of Immunostains Laboratory, providing oversight in clinical test development and diagnostic application.
In addition to her clinical activities, Dr. Rech is active in research with particular emphasis on histiocytic neoplasms including Erdheim-Chester Disease, Rosai-Dorfman Disease and Langerhans Cell Histiocytosis.
Mayo Clinic locations
Education
- 2004
ResidentHematopathology, Programs in Rochester, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine
- 2003
ResidentSurgical & Medical Pathology, Programs in Rochester, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine
- 2002
ResidentAnatomic and Clinical Pathology, Programs in Rochester, Mayo Clinic School of Graduate Medical Education, Mayo Clinic College of Medicine and Science
- 2002
Resident - Anatomic and Clinical PathologyMayo Clinic in Rochester
- 1998
MD - with DistinctionUniversity of North Carolina School of Medicine
- 1993
BS - Biology, with HonorsCalvin College
Activities and honors
Certifications
- 2005
HematologyAmerican Board of Pathology
- 2004
Anatomic & Clinical PathologyAmerican Board of Pathology
Professional memberships
- 2023 - 2027
Rare Histiocytoses Steering CommitteeHistiocyte Society
- 2022 - present
MemberHistiocyte Society
- 2015 - present
Member and CollaboratorMayo Clinic Histiocyte Working Group
Publications